HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)

HE4 is an independent prognostic marker in endometrial cancer patients

(2012) Irene Mutz-Dehbalaie et al.   GYNECOLOGIC ONCOLOGY

The role of novel biomarker HE4 in endometrial cancer: a case control prospective study

(2012) Roberto Angioli et al.   TUMOR BIOLOGY

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

(2011) E Bignotti et al.   BRITISH JOURNAL OF CANCER

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer

(2011) Eleftheria Kalogera et al.   GYNECOLOGIC ONCOLOGY

Patients with atypical hyperplasia of the endometrium should be treated in oncological centers

(2011) Sofie Leisby Antonsen et al.   GYNECOLOGIC ONCOLOGY

Human epididymis protein 4 reference limits and natural variation in a Nordic reference population

(2011) Nils Bolstad et al.   TUMOR BIOLOGY

Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: A multi-center study

(2010) Hee Seung Kim et al.   GYNECOLOGIC ONCOLOGY

Should Preoperative Pathology Be Used to Select Patients for Surgical Staging in Endometrial Cancer?

(2010) Julie A. Francis et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Revised FIGO staging for carcinoma of the endometrium

(2009) William Creasman   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass

(2009) Martina Montagnana et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma

(2008) Mario M. Leitao et al.   GYNECOLOGIC ONCOLOGY

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

(2008)   LANCET

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

(2007) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology

(2007) D.S. CHI et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER